Dr. Ducharme, a neuropsychiatrist at the Neuro was on CJAD to comment on clinical trials in dementia and Alzheimer’s. “Alzheimer’s is a complicated disease. Amyloid is one of the targets…We might need to treat on more than one front.”
New experimental medicines in Alzheimer’s aim to reduce the formation of new amyloid plaques (associated with symptoms of Alzheimer’s) and remove old plaques. The ultimate goal is to preserve and improve brain function.